Predictors and outcomes of increases in creatine phosphokinase concentrations or rhabdomyolysis risk during statin treatment-Reference-Cited by-同舟云学术

Predictors and outcomes of increases in creatine phosphokinase concentrations or rhabdomyolysis risk during statin treatment

Published:2014-08-21 Issue:3 Volume:78 Page:649-659
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

van Staa Tjeerd P.¹²,Carr Daniel F.³,O'Meara Helen³,McCann Gerry⁴,Pirmohamed Munir³

Affiliation:

1. London School of Hygiene & Tropical Medicine; London UK

2. Utrecht Institute for Pharmaceutical Sciences; Utrecht University; Utrecht The Netherlands

3. Department of Molecular and Clinical Pharmacology; Wolfson Centre for Personalised Medicine and MRC Centre for Drug Safety Science; University of Liverpool; Liverpool UK

4. Clinical Practice Research Datalink; Medicines and Healthcare Products Regulatory Agency; London UK

Funder

Medical Research Council

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bcp.12367/fullpdf

Reference27 articles.

1. Statins for the primary prevention of cardiovascular disease;Taylor;Cochrane Database Syst Rev,2013

2. Statin therapy in the prevention of recurrent cardiovascular events: a sex-based meta-analysis;Gutierrez;Arch Intern Med,2012

3. The broad spectrum of statin myopathy: from myalgia to rhabdomyolysis;Harper;Curr Opin Lipidol,2007

4. Rhabdomyolysis associated with hydroxymethylglutaryl-coenzyme A reductase inhibitors;Jamal;Am Heart J,2004

5. Statin myopathy: incidence, risk factors, and pathophysiology;Sewright;Curr Atheroscler Rep,2007

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rosuvastatin-Induced Myopathy: A Case Series;Cureus;2024-08-05

2. Rosuvastatin-induced myopathy in a case of undiagnosed Vitamin D deficiency;Heart India;2023-09

3. Development and application of an algorithm for statin-induced myopathy based on electronic health record-derived structured elements;2023-04-25

4. Comparison of the effect of 40 and 80 mg/day doses of atorvastatin on changes in lipid profiles among acute coronary syndrome patients: A randomized clinical trial study;Journal of Research in Medical Sciences;2023

5. Which four medication classes have important pharmacogenetic considerations?;JAAPA;2023-01